Authors


Aaron S. Farberg, M.D., dermatologist, Baylor Scott & White Health System and Bare Dermatology in Dallas, Texas

Latest:

Impact of Data on Generalized Pustular Psoriasis

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.


Ethan Sims, MD

Latest:

Addressing the Health Impacts of a Changing Climate

Ethan Sims, MD, spoke with Dermatology Times on having positive conversations, cutting down on waste, and how to get involved in change.


Gianna Melendez, MS, Spherix Global Insights

Latest:

Evaluating the Efficacy and Perception of HS Treatment Options

Spherix Global Insights recently delved into the efficacy, patient quality of life, and symptom management of adalimumab vs secukinumab.


Jay A. Lieberman, MD, FACAAI

Latest:

Jay A. Lieberman, MD, FACAAI: Clinical Pearls and Hands-On Educational Opportunities at ACAAI Annual Meeting

Program Chair Jay A. Lieberman, MD, provides a glimpse into the clinical pearls and dermatological educational opportunities presented at the ACAAI 2023 Annual Scientific Meeting.



Hailey Brickman, PA-C

Latest:

QUIZ: Sauna-Related Rash - Test Your Medical Insight

“Edward” is a 35-year-old Hispanic male presenting with a new rash on the buttocks which has been present for approximately 1 month.


Linda Stein Gold, MD

Latest:

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 3

A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.


Jennifer Conner, MPAS, PA-C

Latest:

Take-Home Pearls on the Management of Plaque Psoriasis

Alexa Hetzel, MS, PA-C; Jennifer Conner, MPAS, PA-C; Terry Faleye, MPAS, PA-C; Laura Bush, DMSc, PA-C; and Lakshi Aldredge, MSN, ANP-BC, share take-home messages regarding the treatment of patients with plaque psoriasis, highlighting listening to and educating patients.



Tom Ferry, MBA

Latest:

How Physicians Can Provide Better Care for Patients with Chronic Conditions

Technology and care navigators are key to managing this growing population


Lily Guo

Latest:

Topical Steroid Withdrawal Syndrome Manifesting in Patients Treated for Atopic Dermatitis

Recent studies show patients are experiencing adverse effects of stopping corticosteroid treatment.


Bob Peelman

Latest:

Do You Have the Right Financial Adviser?

Experts detail 5 tips to ask a financial advisor so they can best serve your interests.



James Q. Del Rosso, DO

Latest:

Navigating Acne Management: Balancing Patient Expectations and Optimizing Skincare Regimens - Dr Del Rosso

James Del Rosso, DO, continues the discussion on managing acne in a female patient, emphasizing how to balance patient expectations and optimize skincare regimens, particularly when underlying conditions like polycystic ovarian syndrome are present.


Theresa A. Bingemann, MD, FACAA

Latest:

Exploring the Diagnostics of Urticaria at ACAAI

Session at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting explored issues in understanding and testing for physical urticaria.


Kim Papp, MD, PhD, FRCPC

Latest:

Kim Papp, MD, PhD, FRCPC: Exploring the Potential of ESK-001 in Plaque Psoriasis

Papp shared insights from the recent STRIDE phase 2 trial, which met all its primary and secondary endpoints. Data was presented at the American Academy of Dermatology Annual Meeting.


James Song, MD, FAAD

Latest:

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

James Song, MD, shares a comprehensive guide to what is new, what is now, and what is next in AD treatment.


Iltefat Hamzavi, MD

Latest:

Emerging Therapeutic for Non-Segmental Vitiligo: Merck’s MK-6194

Iltefat Hamzavi, MD, discusses the REGINA 007 phase 2 trial evaluating MK-6194 for the treatment of non-segmental vitiligo.


Marian Freedman

Latest:

Does diet really play a role in acne?

For years, teenagers have been told to avoid certain foods to reduce acne. A review article examines the evidence.



Peter Baek

Latest:

An Overview of Argyria

Argyria is a rare dermatologic condition that presents with blue or grey mucocutaneous discoloration following cutaneous exposure or ingestion of silver.


Matthew Reynolds, PA-C

Latest:

Managing aBCC and aCSCC With Cemiplimab: Tips From Matthew Reynolds, PA-C

Reynolds discussed what attendees need to know about using cemiplimab to target their difficult skin cancer patients at the Fall Clinical Dermatology Conference for PAs and NPs.



Robert J. Casquejo, PA-C

Latest:

Modern Dermatology: Advanced Meds and Social Media Myths

Rob Casquejo, PA-C, spoke with Dermatology Times on new and upcoming medications, addressing unmet needs, and social media misinformation.


Melinda Gooderham, MSc, MD, FRCPC

Latest:

Exploring New Pathways in Atopic Dermatitis

Melinda Gooderham, MSc, MD, FRCPC, discusses potential new biologics for atopic dermatitis that target IL-22, IL-33, OX40, and more.


Jeremy D. Sherer, JD

Latest:

Telehealth in 2023: What Physicians Need to Know

Answers to some common questions about providing telehealth services in 2023.


Adelaide A. Hebert, MD, FAAD

Latest:

Final Thoughts on Tapinarof in AD Clinical Trials

Raj Chovatiya, MD, PhD, and Adelaide A. Hebert, MD, FAAD, review the study results for the ADORING 1 and ADORING 2 trials, as well as share closing thoughts on the use of tapinarof in management of AD.


Glynis Ablon, MD

Latest:

Glynis Ablon, MD, Previews IMCAS World Congress 2024

Ablon’s session highlights include best practices for hair restoration.


Joel M. Gelfand, MD, MSCE, FAAD

Latest:

Shedding LITE on At-Home Phototherapy Treatment for Psoriasis

Get a sneak peek ahead of AAD about the LITE study’s patient-centered design, routine care integration, and diverse participant inclusion, offering a cost-effective option in psoriasis treatment.


Heidi Anne Duerr, MPH

Latest:

Promoting Diversity and Acceptance Through Positive Exposure

Rick Guidotti, fashion photographer turned patient advocate, discusses reframing beauty through his nonprofit Positive Exposure.

© 2024 MJH Life Sciences

All rights reserved.